Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertensionProspective Study Published on 2024-08-212024-09-05 Journal: World journal of gastroenterology [Category] update2024, [키워드] gut microbiota Hepatic encephalopathy Hepatitis B virus portal hypertension Transjugular intrahepatic portosystemic shunt [DOI] 10.3748/wjg.v30.i31.3668 PMC 바로가기 [Article Type] Prospective Study
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessmentReview Article Published on 2024-07-102024-09-05 Journal: Computational and Structural Biotechnology Journal [Category] update2024, [키워드] Hepatic encephalopathy prediction risk Transjugular intrahepatic portosystemic shunt [DOI] 10.1016/j.csbj.2024.07.008 PMC 바로가기 [Article Type] Review Article
A novel imaging index for predicting adverse progression in acute-on-chronic liver failure related to hepatitis B virus: the low erector spine indexarticle Published on 2023-10-262024-09-05 Journal: BMC Gastroenterology [Category] update2024, [키워드] Erector spine mass Hepatic encephalopathy kidney dysfunction liver failure Prognosis [DOI] 10.1186/s12876-023-02995-x PMC 바로가기 [Article Type] article
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisarticle Published on 2023-07-192024-09-05 Journal: The Cochrane database of systematic reviews [Category] update2024, [키워드] ammonia Disaccharides Disaccharides/adverse effects Hepatic encephalopathy Hepatic Encephalopathy/drug therapy humans Liver cirrhosis Liver Cirrhosis/complications Quality of life rifaximin Rifaximin/therapeutic use [DOI] 10.1002/14651858.CD011585.pub2 PMC 바로가기 [Article Type] article
Low Prealbumin Levels Were Associated with Increased Frequency of Hepatic Encephalopathy in Hepatitis B Virus (HBV)-Related Decompensated CirrhosisClinical Research Published on 2023-04-202024-09-05 Journal: Medical science monitor : international medical jo [Category] update2024, [키워드] Hepatic encephalopathy Liver cirrhosis prealbumin [DOI] 10.12659/MSM.937772 PMC 바로가기 [Article Type] Clinical Research
Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trialRandomized Controlled Trial Published on 2022-08-012023-06-11 Journal: Hepatology international [Category] B형 간염, [키워드] Acute-on-chronic liver failure CLIF-C ACLF scores CLIF-C OF score CLIF-SOFA score Hepatic encephalopathy Hepatitis B virus Infection MELD score outcome Thymosin α1 [DOI] 10.1007/s12072-022-10335-6 [Article Type] Randomized Controlled Trial
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort studyArticle Published on 2022-08-012023-06-13 Journal: Hepatology international [Category] B형 간염, [키워드] age CHB Cohort decompensation ETV Hepatic encephalopathy Liver cirrhosis MELD score Propensity score TDF. [DOI] 10.1007/s12072-022-10357-0
Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventionsReview Published on 2022-07-282023-06-12 Journal: World journal of gastroenterology [Category] B형 간염, [키워드] fecal microbiota transplantation gut microbiota Hepatic encephalopathy Hepatitis B virus Liver cirrhosis Liver fibrosis [DOI] 10.3748/wjg.v28.i28.3555 PMC 바로가기 [Article Type] Review
A dynamic nomogram to predict transplant-free mortality in patients with hepatitis B-related cirrhosis and overt hepatic encephalopathyArticle Published on 2022-07-012023-06-12 Journal: International immunopharmacology [Category] B형 간염, [키워드] cirrhosis Hepatic encephalopathy Neutrophil-to-lymphocyte ratio Prognosis [DOI] 10.1016/j.intimp.2022.108879
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial간경변 환자에서 양성자 펌프 억제제 치료 중단(STOPPIT): 전향적, 다기관, 대조, 무작위, 이중 맹검 시험을 위한 연구 프로토콜Article Published on 2022-04-122022-09-11 Journal: Trials [Category] COVID19(2023년), SARS, 임상, [키워드] 1:1 bleeding bleeding event cirrhosis clinical Clinical outcome clinical outcomes clinical trial complications composite endpoint control group death defined Diagnosis double-blind trial double-blinded Effect Endpoint Esomeprazole EU Clinical Trials EudraCT evaluate excluded gastritis gastrointestinal bleeding Germany Hemorrhagic hepatic Hepatic encephalopathy Hospitalization Hospitalized Hypothesis IMPROVE include increased risk indication infections Infectious complications inhibitor intervention group intestinal liberal liver Liver cirrhosis liver failure manifestation medication microbiota Mortality multicentre observational studies observational study Occurrence outcome Pantoprazole parallel-group Patient peptic ulcer Placebo placebo-controlled PPI primary composite endpoint Prophylactic Proton-pump inhibitors Randomized rationale receive recruitment reflux esophagitis Registered risk secondary Secondary endpoints Side-effects STOP Study protocol therapy Treatment Trial variable Withdrawal [DOI] 10.1186/s13063-022-06232-w PMC 바로가기 [Article Type] Article